HONMA ICHIYA 本間一也

Researcher Number	20404676
Affiliation (based on the past Project Information) *help	2006 – 2008: 札幌医科大学, 医学部, 研究員
Review Section/Research Field	Except Principal Investigator Urology
Keywords	Except Principal Investigator HLA cell I抗原 / 腎細胞癌 / HLA class I抗原 / 癌抗原 / サバイビン / がん抗原 / 免疫療法 / 尿路上皮癌

Establishment of survivin-derived peptide vaccination for patients with urothelial cancer
- Principal Investigator
  
  TSUKAMOTO Taiji
- Project Period (FY)
  2005 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Sapporo Medical University

All 2009 2008 2007 2006 2005 Other

All Journal Article Presentation

[Journal Article] Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer2009
- Author(s)
  Honma I, Kitamura H, Torigoe T, Takahashi A, Tanaka T, Sato E, Hirohashi Y, Masumori N, Tsukamoto T, Sato N.
- Journal Title
  
  Cancer Immunol Immunother [Epub ahead of print]
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma2008
- Author(s)
  Sato E, Torigoe T, Hirohashi Y, Kitamura H, Tanaka T, Honma I, Asanuma H, Harada K, Takasu H, Masumori N, Ito N, Hasegawa T, Tsukamoto T, Sato N.
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6916-23
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Phase I clinical study of anti-apoptosis protein survivcn-derived peptide vaccination for patients with advanced or recurrent urothelial cancer2008
- Author(s)
  Honma I
- Journal Title
  
  Cancer Imunol Immunother May 18(Published online)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic lymph node deissecion2006
- Author(s)
  Honma I, et al.
- Journal Title
  
  Urology 68
  
  Pages: 543-548
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer : implications for specific immunotherapy
- Author(s)
  Kitamura H, Torigoe T, Honma I, Asanuma H, Nakazawa E, Shimozawa K, Hirohashi Y, Sato E, Sato N, Tsukamoto T.
- Journal Title
  
  Urology 2006 67
  
  Pages: 955-959
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Down-regulation of HLA Class I Antigen Is an Independent Prognostic Factor for Clear Cell Renal Cell Carcinoma
- Author(s)
  Kitamura H, Honma I, Torigoe T, Asanuma H, Sato N, Tsukamoto T.
- Journal Title
  
  J Urol 2007 177
  
  Pages: 1269-72
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus Calmette- Guerin immunotherapy for bladder cancer
- Author(s)
  Kitamura H, Torigoe T, Honma I, Sato E, Asanuma H, Hirohashi Y, Sato N, Tsukamoto T.
- Journal Title
  
  Clin Cancer Res 2006 12
  
  Pages: 4641-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients
- Author(s)
  Kitamura H, Honma I, Torigoe T, Hariu H, Asanuma H, Hirohashi Y, Sato E, Sato N, Tsukamoto T.
- Journal Title
  
  Urology 2007 70
  
  Pages: 38-42
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Journal Article] Down-regulation of HLA Class I Antigens in Prostate Cancer Tissues and Up-regulation by Histone Deacetylase Inhibition
- Author(s)
  Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto T.
- Journal Title
  
  J Urol 2007 178
  
  Pages: 692-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] <Workshop : Urothelial Cell Cancer> Phase I clinical study of anti-apopotosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent urothelial cancer2008
- Author(s)
  Honma I., Kitamura H, Torigoe T, Hirohashi Y, Sato E, Takahashi A, Taguchi K, Masumori N, Itoh N, Sato N, Tsukamoto T.
- Organizer
  第96回日本泌尿器科学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] HIF prolyl hydroxylase 3(HIFPH3)を標的とした腎細胞癌に対する新規癌免疫療法開発に向けた基礎的研究2008
- Author(s)
  佐藤英次、鳥越俊彦、廣橋良彦、本間一也、北村寛、中津川宗秀、井野田智子、桐山賢二、舛森直哉、伊藤直樹、塚本泰司、佐藤昇志
- Organizer
  第96回日本泌尿器科学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] <Workshop : Urothelial Cell Cancer> Phase I clinical study of anti-apoptosis protein, surviving-derived peptide vaccine therapy for patients with advanced or recurrent urothelial cancer2008
- Author(s)
  Honma I
- Organizer
  第96回日本泌尿器科学会総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] Phase I clinical study of anti-apoptosis protein, surviving-derived peptide. Vaccine therapy for patients wit advanced or recurrent urotheial cancer2007
- Author(s)
  Honma I, et. al.
- Organizer
  第102回アメリカ泌尿器科学会
- Place of Presentation
  アナハイム(カリフォルニア)
- Year and Date
  2007-05-21
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] 【ワークショップ】新規腫瘍マーカーの臨床応用:新規単クローン抗体による泌尿器癌におけるHLA class I down-regulation解析と臨床所見2007
- Author(s)
  本間一也
- Organizer
  第95回日本泌尿器科学会総会
- Place of Presentation
  神戸市
- Year and Date
  2007-04-15
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] Phase I clinical study of anti-apoptosis protein, survivin-derived peptide. Vaccine therapy for patients with advanced or recurrent urothelial cancer2007
- Author(s)
  Honma I, Kitamura H, Torigoe T, Hirohashi Y, Shimozawa K, Takahashi A, Sato E, Takahashi A, Taguchi K, Masumori N, Itoh N, Sato N, Tsukamoto T.
- Organizer
  第102回アメリカ泌尿器科学会
- Place of Presentation
  アナハイム(カリフォルニア)
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] [ワークショップ]新規腫瘍マーカーの臨床応用 : 新規単クローン抗体による泌尿器癌におけるHLA class I down-regulation解析と臨床所見2007
- Author(s)
  本間一也
- Organizer
  第95回日本泌尿器科学会総会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] 前立腺癌におけるHLA class I down-regulationと免疫逃避2006
- Author(s)
  北村寛、鳥越俊彦、浅沼広子、本間一也、佐藤英次、舛森直哉、佐藤昇志、塚本泰司
- Organizer
  第15回泌尿器科分子・細胞研究会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] 新規開発単クローン抗体によるHLAクラスI final output解析と膀胱癌BCG局所注入療法の有効性の相関2005
- Author(s)
  北村寛、鳥越俊彦、浅沼広子、本間一也、佐藤英次、廣橋良彦、中澤恵実理、高橋敦、舛森直哉、塚本泰司、佐藤昇志
- Organizer
  第64回日本癌学会総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] 病理標本で解析し得る新規単クローン抗体EMR8-5を用いた泌尿器科悪性腫瘍HLA class I発現の検討2005
- Author(s)
  北村寛、鳥越俊彦、本間一也、佐藤英次、中澤恵実理、廣橋良彦、浅沼広子、塚本泰司、佐藤昇志
- Organizer
  第35回日本免疫学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17390441
[Presentation] 膀胱癌におけるIAP family分子survivinの発現と抗原性の解析2005
- Author(s)
  北村寛、鳥越俊彦、本間一也、浅沼広子、小林淳一、真野佳典、中澤恵実理、佐藤英次、塚本泰司、佐藤昇志
- Organizer
  第9回基盤的癌免疫研究会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-17390441

1. TSUKAMOTO Taiji (50112454)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
2. SATO Noriyuki (50158937)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
3. MASUMORI Naoya (20295356)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
4. TANAKA Toshiaki (50398327)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. SATO EIJI (30404677)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
6. 高橋敦 (20274946)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results

HONMA ICHIYA 本間 一也

Research Projects

Research Products

Co-Researchers

Establishment of survivin-derived peptide vaccination for patients with urothelial cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer2009

Author(s)

Journal Title

Data Source

[Journal Article] Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma2008

Author(s)

Journal Title

Data Source

[Journal Article] Phase I clinical study of anti-apoptosis protein survivcn-derived peptide vaccination for patients with advanced or recurrent urothelial cancer2008

Author(s)

Journal Title

Data Source

[Journal Article] Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic lymph node deissecion2006

Author(s)

Journal Title

Data Source

[Journal Article] Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer : implications for specific immunotherapy

Author(s)

Journal Title

Data Source

[Journal Article] Down-regulation of HLA Class I Antigen Is an Independent Prognostic Factor for Clear Cell Renal Cell Carcinoma

Author(s)

Journal Title

Data Source

[Journal Article] Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus Calmette- Guerin immunotherapy for bladder cancer

Author(s)

Journal Title

Data Source

[Journal Article] Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients

Author(s)

Journal Title

Data Source

[Journal Article] Down-regulation of HLA Class I Antigens in Prostate Cancer Tissues and Up-regulation by Histone Deacetylase Inhibition

Author(s)

Journal Title

Data Source

[Presentation] <Workshop : Urothelial Cell Cancer> Phase I clinical study of anti-apopotosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent urothelial cancer2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] HIF prolyl hydroxylase 3(HIFPH3)を標的とした腎細胞癌に対する新規癌免疫療法開発に向けた基礎的研究2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] <Workshop : Urothelial Cell Cancer> Phase I clinical study of anti-apoptosis protein, surviving-derived peptide vaccine therapy for patients with advanced or recurrent urothelial cancer2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Phase I clinical study of anti-apoptosis protein, surviving-derived peptide. Vaccine therapy for patients wit advanced or recurrent urotheial cancer2007

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 【ワークショップ】新規腫瘍マーカーの臨床応用:新規単クローン抗体による泌尿器癌におけるHLA class I down-regulation解析と臨床所見2007

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Phase I clinical study of anti-apoptosis protein, survivin-derived peptide. Vaccine therapy for patients with advanced or recurrent urothelial cancer2007

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] [ワークショップ]新規腫瘍マーカーの臨床応用 : 新規単クローン抗体による泌尿器癌におけるHLA class I down-regulation解析と臨床所見2007

Author(s)

HONMA ICHIYA 本間一也